Hebao
Signal active
Organization
Contact Information
Overview
Hebao Pharmaceutical is an innovative Chinese patent medicine developer, focusing on screening anti-tumor Chinese medicine prescriptions on the clinical basis of Chinese medicine, and developing innovative anti-tumor Chinese patent medicines. Its products include Gevofron Hefuping and Gevory Heleneng, which have multi-target anti-tumor drugs. Tumor and improve autoimmunity and resistance and other effects.
About
Industries
Biotechnology, Pharmaceutical, Medical, Personal Health
Founded
2018
Employees
51-100
Headquarters locations
Hangzhou, Zhejiang, China, Asia
Social
Profile Resume
Hebao headquartered in Asia, operates in the Biotechnology, Pharmaceutical, Medical, Personal Health sector. With a team of 51-100 employees, Hebao is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Hebao, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
1
Investors
1
Lead Investors
0
Total Funding Amount
$0
Details
0
Hebao has raised a total of $0 in funding over 0 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|
Investors
Hebao is funded by 2 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Hebao | - | FUNDING ROUND - Hebao | undefined |
| Unilever | - | FUNDING ROUND - Unilever | undefined |